Inovio Pharmaceuticals, Inc.

Ownership Transactions Reported by 12 Insiders

Symbol
INO on Nasdaq
Location
660 W. Germantown Pike, Suite 110, Plymouth Meeting, PA

There are no Buy or Sell transactions made by insiders since 10/4/2024

Inovio Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Jong Joseph Kim Chief Executive Officer, Director $2.45M Mar 11, 2022
Jacqueline E. Shea Chief Executive Officer, Director $285K May 20, 2025
David B. Weiner Director $192K May 21, 2025
Michael John Sumner Chief Medical Officer $141K Jun 30, 2025
Peter Kies Cfo $123K May 20, 2025
Laurent Humeau Chief Scientific Officer $107K May 20, 2025
Simon X. Benito Director $51.1K May 21, 2025
Wendy L. Yarno Director $48K May 21, 2025
Ann C. Miller Director $46.8K May 21, 2025
Jay Shepard Director $45.5K May 21, 2025
Roger D. Dansey Director $45K May 21, 2025
Lota S. Zoth Director $44.6K May 21, 2025

Recent Insider Transactions by Companies or Individuals for Inovio Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.